首页> 美国卫生研究院文献>other >Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida
【2h】

Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida

机译:人宫颈干细胞条件培养基(hUCESC-CM)对白色念珠菌和其他与念珠菌相关的药物的抗真菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Candidiasis is a major cause of human morbidity and mortality. Human uterine cervical stem cells conditioned medium (hUCESC-CM) is obtained from stromal stem cells of the cervical transformation zone, which are in permanent contact with a wide array of potential vaginal pathogens. In previous reports we have found that hUCESC-CM has antitumor and antibacterial potential. Since Candida is the most prevalent yeast in the human vagina, it seems plausible that hUCESC-CM might also show activity against it.>Methods: In a preliminary step, to evaluate if hUCESC-CM showed any activity at all on Candida growth, in vitro activities of hUCESC-CM against fluconazole-susceptible reference strains of Candida albicans, Candida glabrata, Candida krusei, and Candida parapsilosis were studied with a microdilution method on RPMI 1640, using the BioScreen C microbiological incubator. Each measurement was repeated five times. The same methodology was used subsequently on fluconazole-susceptible and fluconazole-resistant Candida isolates from blood and vagina of those species corresponding to the reference strains of Candida against which activity had been detected in the previous study. Moreover, two fluconazole-resistant clinical isolates of Candida auris from blood and urine were also included.>Findings: In vitro inhibitory activity of hUCESC-CM ranged from 57.5 to 96.6% growth-reduction against fluconazole-susceptible reference strains of Candida albicans, Candida glabrata, and Candida parapsilosis. hUCESC-CM also reduced the growth of all fluconazole-susceptible tested vaginal isolates by more than 50%. For fluconazole-resistant isolates, growth-reduction was higher than 67% for Candida albicans, regardless of its origin (vagina or blood). The isolate of Candida auris from urine with a MIC > 128 μ/ml for fluconazole was also significantly inhibited. However, hUCESC-CM was almost inactive against any of the fluconazole-resistant blood isolates of Candida glabrata, Candida parapsilosis, and Candida auris tested.>Interpretation: This is the first report about the growth-inhibiting properties of conditioned medium from human stromal stem cells against different species of Candida. Antifungal activity of stromal stem cells depends on their site of origin, being most effective against Candida species most prevalent at that particular location. If confirmed in further studies, these findings might result in a completely new therapeutic approach against superficial and invasive candidiasis.
机译:>背景:念珠菌病是人类发病和死亡的主要原因。人子宫宫颈干细胞条件培养基(hUCESC-CM)是从宫颈转化区的基质干细胞中获得的,它们与各种潜在的阴道病原体保持永久接触。在以前的报告中,我们发现hUCESC-CM具有抗肿瘤和抗菌潜力。由于念珠菌是人类阴道中最普遍的酵母菌,因此hUCESC-CM也可能显示出对它的活性。>方法:在初步步骤中,评估hUCESC-CM在所有关于念珠菌的生长,使用BioScreen C微生物培养箱在RPMI 1640上用微量稀释法研究了hUCESC-CM对白色念珠菌,光滑念珠菌,克鲁斯念珠菌和副念珠菌敏感的氟康唑敏感性参考菌株的体外活性。每次测量重复五次。随后,对与先前研究中已检测到活性的念珠菌参考菌株相对应的那些物种的血液和阴道中的氟康唑敏感和耐氟康唑的念珠菌分离株使用了相同的方法。此外,还包括从血液和尿液中获得的两种耐氟康唑抗性假丝酵母临床分离株。>发现: hUCESC-CM在体外对氟康唑敏感性参考的抑制作用范围为57.5至96.6%。白色念珠菌,光滑念珠菌和副念珠菌的菌株。 hUCESC-CM还使所有对氟康唑敏感的经测试阴道分离株的生长减少了50%以上。对于耐氟康唑的分离株,白色念珠菌的生长减少率高于67%,而不论其起源(阴道或血液)如何。氟康唑的MIC> 128μ/ ml从尿中分离出假丝酵母。但是,hUCESC-CM几乎对经测试的光滑念珠菌,副念珠菌和耳霉念珠菌的任何耐氟康唑的血液分离物均无活性。>解释:人基质干细胞针对不同种类念珠菌的条件培养基。基质干细胞的抗真菌活性取决于其起源部位,对特定位置上最普遍的物种最有效。如果在进一步的研究中得到证实,这些发现可能会导致针对表皮和浸润性念珠菌病的全新治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号